| Affiliation: | 1. CR-UK Department of Medical Oncology, Christie Hospital, Manchester, UK M20 4BX;2. Tumour Biochemistry Laboratory, Christie Hospital, Manchester, UK M20 4BX;1. UCSF Benioff Children’s Hospital Oakland Research Institute (CHORI), Oakland, CA, USA;2. Institute of Metabolism and Systems Research (IMSR), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;1. Department of Pharmacology and Toxicology;2. Department of Medicine;3. James Graham Brown Cancer Center;4. Center for Predictive Medicine, University of Louisville School of Medicine, Louisville, Kentucky;5. University of Lille, Centre national de la recherche scientifique, INSERM, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, U1019, UMR 8204, Center for Infection and Immunity of Lille, Lille, France;6. PhoenixBio USA Corporation, New York, New York;1. Nuclear Organization and Oncogenesis Unit, Institut Pasteur, Équipe Labellisée Ligue Nationale Contre le Cancer, 75015 Paris, France;2. INSERM, U993, 75015 Paris, France;3. Sorbonne Université, Collège Doctoral, 75005 Paris, France;4. Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark;1. State Key Laboratory of Molecular Biology, National Center for Protein Science Shanghai, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China;2. University of Chinese Academy of Sciences, Beijing 100049, China;3. National Facility for Protein Science in Shanghai, Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Science, Shanghai 201210, China;4. School of Life Science and Technology, Shanghai Tech University, Shanghai 201210, China |
